Stock Scorecard



Stock Summary for Eton Pharmaceuticals Inc (ETON) - $3.80 as of 3/28/2024 12:05:39 AM EST

Total Score

11 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ETON

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ETON

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ETON

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for ETON

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for ETON

Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE 3/22/2024 6:00:00 AM
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria 3/22/2024 6:00:00 AM
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria 3/22/2024 6:00:00 AM
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria - Relief Therapeutics ( OTC:RLFTF ) , Eton Pharmaceuticals ( NASDAQ:ETON ) 3/22/2024 6:00:00 AM
Eton Pharmaceuticals, Inc. ( ETON ) Reports Q4 Loss, Lags Revenue Estimates 3/14/2024 9:15:00 PM
Cardiff Oncology ( CRDF ) Reports Q4 Loss, Tops Revenue Estimates 3/1/2024 12:40:00 AM
Iovance Biotherapeutics ( IOVA ) Reports Q4 Loss, Misses Revenue Estimates 2/28/2024 10:35:00 PM
Eton Pharma ( ETON ) to Report Q4 Earnings: What's in the Cards? 2/26/2024 1:19:00 PM
Moderna ( MRNA ) Q4 Earnings and Revenues Beat Estimates 2/22/2024 12:40:00 PM
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation 2/21/2024 11:50:00 AM

Financial Details for ETON

Company Overview

Ticker ETON
Company Name Eton Pharmaceuticals Inc
Country USA
Description Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. The company is headquartered in Deer Park, Illinois.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/9/2024

Stock Price History

Last Day Price 3.80
Last Day Price Updated 3/28/2024 12:05:39 AM EST
Last Day Volume 34,823
Average Daily Volume 69,160
52-Week High 5.81
52-Week Low 2.42
Last Price to 52 Week Low 57.02%

Valuation Measures

Trailing PE N/A
Industry PE 100.07
Sector PE 60.76
5-Year Average PE -26.61
Free Cash Flow Ratio 4.58
Industry Free Cash Flow Ratio 12.70
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 1.65
Total Cash Per Share 0.83
Book Value Per Share Most Recent Quarter 0.60
Price to Book Ratio 6.32
Industry Price to Book Ratio 5.57
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 3.09
Industry Price to Sales Ratio Twelve Trailing Months 13.94
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 25,688,100
Market Capitalization 97,614,780
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -12.60%
Annual Earnings Growth 89.62%
Reported EPS 12 Trailing Months -0.04
Reported EPS Past Year -0.06
Reported EPS Prior Year -0.35
Net Income Twelve Trailing Months -936,000
Net Income Past Year -936,000
Net Income Prior Year -9,021,000
Quarterly Revenue Growth YOY -13.90%
5-Year Revenue Growth 0.00%

Balance Sheet

Total Cash Most Recent Quarter 21,388,000
Total Cash Past Year 21,388,000
Total Cash Prior Year 16,305,000
Net Cash Position Most Recent Quarter 21,388,000
Net Cash Position Past Year 21,388,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 5,384,000
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 15,477,000
Total Stockholder Equity Prior Year 13,078,000
Total Stockholder Equity Most Recent Quarter 15,477,000

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.18
MACD Signal -0.16
20-Day Bollinger Lower Band 3.49
20-Day Bollinger Middle Band 4.19
20-Day Bollinger Upper Band 4.88
Beta 1.19
RSI 40.23
50-Day SMA 3.98
200-Day SMA 4.87

System

Modified 3/28/2024 12:05:39 AM EST